【HMD BioMedical Inc.】Q1 2026 EPS NT$0.39
NQ Score
0/100
N1 Content Completeness
2
AI Summary (NQ-processed)
HMD BioMedical Inc., a company in the biotechnology and medical care industry, announced its financial results for the first quarter of 2026. The company reported basic earnings per share of NT$0.39, operating revenue of NT$384 million, and a net profit of NT$64 million.